Heterogeneity of Low-Density Lipoprotein Particle Number in Patients With Type 2 Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl
- 23 October 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (12) , 1599-1602
- https://doi.org/10.1016/j.amjcard.2006.07.036
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention TrialCirculation, 2006
- Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panelJournal of Internal Medicine, 2006
- Increased Small Low-Density Lipoprotein Particle NumberCirculation, 2006
- Assessment of Reaching Goal in Patients with Combined Hyperlipidemia: Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, or Apolipoprotein BThe American Journal of Cardiology, 2005
- Reducing Residual Risk for Patients on Statin Therapy: The Potential Role of Combination TherapyThe American Journal of Cardiology, 2005
- Low-density lipoprotein particle number and risk for cardiovascular diseaseCurrent Atherosclerosis Reports, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentThe Lancet, 2003
- Measurement issues related to lipoprotein heterogeneityThe American Journal of Cardiology, 2002